Prothena Corp. (PRTA) Misses Q3 EPS by 4c

Go back to Prothena Corp. (PRTA) Misses Q3 EPS by 4c

Deutsche Bank Starts Prothena Corp (PRTA) at Buy

November 3, 2016 6:49 AM EDT

Deutsche Bank initiated coverage on Prothena Corp (NASDAQ: PRTA) with a Buy rating and a price target of $73. Analyst Andrew Peters sees Prothena as a "compelling story."

"We view PRTA as a fundamentally strong story with a well-spaced catalyst path across three clinical... More